A global clinical research data sharing platform
The Vivli team is dedicated to helping researchers share and access data from clinical trials to advance science.

We are committed to advancing the knowledge around the COVID-19 pandemic

Share COVID studies    Search for studies

Clinical Trials

Our Members

Pfizer logoAbbvie logoImmport bioinformaticsHelmsley charitable trust logoJohns Hopkins university logoUniversity of california san francisco logoDoris duke charitable foundation logoLilly logoJohnson & Johnson logoCure Duchenne logoUCB logoRegeneron logoRoche logoLundback logoTaiho logoKyowa kirin logoBristol Myers Squibb logoOtsuka logoAlnylam logoBill and melinda gates foundationAstra Zeneca logoStanford University
Why we support Vivli
quote image
We are proud we are able to take this step forward in our data sharing program as part of our ongoing data transparency commitments.
Jenny Petersen, Director, Clinical Trial Disclosure and Transparency at Alnylam Pharmaceuticals
quote image
We are committed to increasing the impact of the research we fund so that it is open and accessible to all through platforms like the one developed by Vivli.
Steven Kern, Ph.D., Deputy Director, Quantitative Sciences, The Bill & Melinda Gates Foundation
quote image
Through Vivli, we will strengthen our external data sharing capabilities with best-in-class research tools and the Wellcome Trust Independent Review Panel (IRP) in service of advancing human health.
Julie Holtzople, Head of Clinical Transparency and Data Sharing at AstraZeneca
quote image
During this critical time of public health challenge, we welcome the opportunity to work with a trusted partner.
Jeff Helterbrand, Global Biometrics Head at Roche
quote image
We’ve made an important piece of research and important contribution to the field, which would have been impossible without the sharing of data.
Professor José António P. Da Silva, University of Coimbra
quote image
The mission of Vivli is fully aligned with that of Harvard University in promoting collaborative research and data sharing and transparency.
Ara Tahmassian, Ph.D., Chief Research Compliance Officer at Harvard University
quote image
UCB is proud to support the work that the Vivli team is undertaking to drive collaboration and data sharing, as we believe this will enhance disease understanding, generate new insights, and may help develop new treatments to benefit patients worldwide.
Professor Dr. Iris Loew-Friedrich, chief medical officer and executive vice president, UCB
Vivli 2021 Progress ReportFULL STORY
Watch the Video: The Difference Re-Using Data Can MakeFULL STORY

Updates & Events

Vivli CEO Rebecca Li to participate in panel discussion for Harnessing the Potential of Patient-Level data in Clinical Trials     
» More
Vivli launches Case Studies to showcase the work of our innovative researchers
» More
Vivli Researcher Spotlight: Making an Impact in Oncology Treatment Using Individual Patient-Level Data
» More